Levetiracetam

Product NDC: 65862-250
11-digit product format: 658620250
Labeler code: 65862
Product ID: 65862-250_8cd74ce7-ea18-456e-bc82-34b643055e56
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Levetiracetam
Dosage form: SOLUTION
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA079063
Marketing category: ANDA
Marketing start: 2009-01-15
Substance: LEVETIRACETAM
Active strength: 100 mg/mL
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A079063-001	LEVETIRACETAM	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA		2009-01-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A079063-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A079063-001	LEVETIRACETAM	100MG/ML	SOLUTION / ORAL	AA	2009-01-15	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A079063-001	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079063-001	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A079063-001	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079063-001	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079063-001	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A079063-001	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A079063-001	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A079063-001	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A079063-001	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A079063-001	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A079063-001	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A079063-001	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A079063-001	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A079063-001	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A079063-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A079063-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A079063-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A079063-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A079063-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A079063-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A079063-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A079063-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A079063-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A079063-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A079063-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A079063-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A079063-001	AA	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A079063-001	AA	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A079063-001	AA	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A079063-001	AA	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A079063-001	AA	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A079063-001	AA	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A079063-001	AA	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A079063-001	AA	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A079063-001	AA	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A079063-001	AA	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A079063-001	AA	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A079063-001	AA	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A079063-001	AA	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A079063-001	AA	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Levetiracetam
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LEVETIRACETAM	100 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
44YRR34555	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
403884	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f65ec19d-b90e-452e-b761-c68b1cf2c892	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
76e81f18-c6b9-f226-530a-a6296d5cd5f4	Product name	6	20251106
087c9486-f4a9-a565-c6fb-d6fa49f4572a	Product name	6	20230317
525a8d4d-1988-fc3f-e292-27fd384de4f0	Product name	8	20230104
32b651f8-caa7-6882-11c7-54c4ad21796b	Product name	8	20201216
ce453ca5-90cf-41ed-9de4-de519f70a0f2	Product name	2	20160303
66666eb8-1fa6-4a60-bae9-e564e73b4cd5	Product name	1	20150728
eecbc0ef-ab5c-4ff9-8aaa-6ea73ee46477	Product name	1	20150410

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
65862-250-05	Levetiracetam	500 mL in 1 BOTTLE, PLASTIC	SOLUTION	500		26
65862-250-47	Levetiracetam	473 mL in 1 BOTTLE, PLASTIC	SOLUTION	473		26

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65862-250-47	ML - Milliliter	65862-250	e1061a17-c5ee-4eda-bca7-ef0831df069d	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LEVETIRACETAM	ACTIVE INGREDIENT	44YRR34555	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
LEVETIRACETAM	ACTIVE MOIETY	44YRR34555	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
ACESULFAME POTASSIUM	INACTIVE INGREDIENT	23OV73Q5G9	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
GLYCYRRHIZIN, AMMONIATED	INACTIVE INGREDIENT	3VRD35U26C	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
MALTITOL	INACTIVE INGREDIENT	D65DG142WK	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
TRISODIUM CITRATE DIHYDRATE	INACTIVE INGREDIENT	B22547B95K	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14
WATER	INACTIVE INGREDIENT	059QF0KO0R	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65862-250	LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED]	26	Current NDC, Legacy NDC, 2 package rows	20240918_f65ec19d-b90e-452e-b761-c68b1cf2c892.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Levetiracetam	LEVETIRACETAM	REMEDYREPACK INC.	94d042f7-93b9-43bd-9ace-cfc61903b4d7	2026-06-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079063 application number: ANDA079063
Levetiracetam	LEVETIRACETAM	REMEDYREPACK INC.	74ccc9f1-b957-4b1b-9464-1b5e3318c916	2026-06-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079063 application number: ANDA079063
Levetiracetam	LEVETIRACETAM	NorthStar Rx LLC	483a42b9-c8f3-4f8b-98be-fcac5ab23c7c	2024-10-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079063 application number: ANDA079063
Levetiracetam	LEVETIRACETAM	Aurobindo Pharma Limited	f65ec19d-b90e-452e-b761-c68b1cf2c892	2024-09-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079063 application number: ANDA079063 ndc (product): 65862-250

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
44YRR34555	LEVETIRACETAM	102767-28-2	LEVETIRACETAM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
403884	levETIRAcetam 100 MG in 1 mL Oral Solution	PSN	f65ec19d-b90e-452e-b761-c68b1cf2c892	26
403884	levetiracetam 100 MG/ML Oral Solution	SCD	f65ec19d-b90e-452e-b761-c68b1cf2c892	26
403884	levetiracetam 100 MG per 1 ML Oral Solution	SY	f65ec19d-b90e-452e-b761-c68b1cf2c892	26
403884	levetiracetam 1000 MG per 10 ML Oral Solution	SY	f65ec19d-b90e-452e-b761-c68b1cf2c892	26
403884	levetiracetam 1500 MG per 15 ML Oral Solution	SY	f65ec19d-b90e-452e-b761-c68b1cf2c892	26
403884	levetiracetam 500 MG per 5 ML Oral Solution	SY	f65ec19d-b90e-452e-b761-c68b1cf2c892	26
403884	levETIRAcetam 100 MG in 1 mL Oral Solution	PSN	94d042f7-93b9-43bd-9ace-cfc61903b4d7	9
403884	levetiracetam 100 MG/ML Oral Solution	SCD	94d042f7-93b9-43bd-9ace-cfc61903b4d7	9
403884	levetiracetam 100 MG per 1 ML Oral Solution	SY	94d042f7-93b9-43bd-9ace-cfc61903b4d7	9
403884	levetiracetam 1000 MG per 10 ML Oral Solution	SY	94d042f7-93b9-43bd-9ace-cfc61903b4d7	9
403884	levetiracetam 1500 MG per 15 ML Oral Solution	SY	94d042f7-93b9-43bd-9ace-cfc61903b4d7	9
403884	levetiracetam 500 MG per 5 ML Oral Solution	SY	94d042f7-93b9-43bd-9ace-cfc61903b4d7	9
403884	levETIRAcetam 100 MG in 1 mL Oral Solution	PSN	74ccc9f1-b957-4b1b-9464-1b5e3318c916	6
403884	levetiracetam 100 MG/ML Oral Solution	SCD	74ccc9f1-b957-4b1b-9464-1b5e3318c916	6
403884	levetiracetam 100 MG per 1 ML Oral Solution	SY	74ccc9f1-b957-4b1b-9464-1b5e3318c916	6
403884	levetiracetam 1000 MG per 10 ML Oral Solution	SY	74ccc9f1-b957-4b1b-9464-1b5e3318c916	6
403884	levetiracetam 1500 MG per 15 ML Oral Solution	SY	74ccc9f1-b957-4b1b-9464-1b5e3318c916	6
403884	levetiracetam 500 MG per 5 ML Oral Solution	SY	74ccc9f1-b957-4b1b-9464-1b5e3318c916	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
65862-250-05	65862025005	500 mL in 1 BOTTLE, PLASTIC (65862-250-05)	500 ml	2009-01-15	0000-00-00	No	No	Current
65862-250-47	65862025047	473 mL in 1 BOTTLE, PLASTIC (65862-250-47)	473 ml	2009-01-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Levetiracetam	REMEDYREPACK INC.	2026-06-08	HUMAN PRESCRIPTION DRUG LABEL	10
Levetiracetam	REMEDYREPACK INC.	2026-06-08	HUMAN PRESCRIPTION DRUG LABEL	7
Levetiracetam	Aurobindo Pharma Limited \| APL HEALTHCARE LIMITED	2024-09-12	Human Prescription Drug Label	26
Levetiracetam	REMEDYREPACK INC.	2022-12-27	HUMAN PRESCRIPTION DRUG LABEL	1